APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acute Kidney Injury Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acute Kidney Injury Drugs Market Analysis and Forecast 2026-2032

Report ID 173960320222 December 2025198 pages

Choose your research edition.

Industry ResearchAcute Kidney Injury Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Kidney Injury Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Acute Kidney Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Kidney Injury Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Kidney Injury Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Acute Kidney Injury Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Acute Kidney Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acute Kidney Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acute Kidney Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acute Kidney Injury Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Acute Kidney Injury Drugs include Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Quark Pharmaceuticals, Baxter International, LG Chem, Asahi Kasei Medical and Angion Biomedica Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Acute Kidney Injury Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acute Kidney Injury Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Acute Kidney Injury Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acute Kidney Injury Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acute Kidney Injury Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Acute Kidney Injury Drugs sales, projected growth trends, production technology, application and end-user industry.

Acute Kidney Injury Drugs Segment by Company

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Quark Pharmaceuticals

Baxter International

LG Chem

Asahi Kasei Medical

Angion Biomedica Corp

Acute Kidney Injury Drugs Segment by Type

Intrinsic Acute Kidney Injury

Postrenal Acute Kidney Injury

Prerenal Acute Kidney Injury

Others

Acute Kidney Injury Drugs Segment by Application

Hospital

Clinic

Acute Kidney Injury Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Kidney Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Kidney Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Kidney Injury Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Acute Kidney Injury Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Acute Kidney Injury Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Kidney Injury Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acute Kidney Injury Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intrinsic Acute Kidney Injury Major Manufacturers Table 3. Postrenal Acute Kidney Injury Major Manufacturers Table 4. Prerenal Acute Kidney Injury Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Acute Kidney Injury Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Acute Kidney Injury Drugs Industry Trends Table 10. Acute Kidney Injury Drugs Industry Drivers Table 11. Acute Kidney Injury Drugs Industry Opportunities and Challenges Table 12. Acute Kidney Injury Drugs Industry Restraints Table 13. Global Acute Kidney Injury Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Acute Kidney Injury Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Acute Kidney Injury Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Acute Kidney Injury Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Acute Kidney Injury Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Acute Kidney Injury Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Acute Kidney Injury Drugs Sales by Region (2021-2026) & (k units) Table 20. Global Acute Kidney Injury Drugs Sales by Region (2027-2032) & (k units) Table 21. Global Acute Kidney Injury Drugs Sales Market Share by Region (2021-2026) Table 22. Global Acute Kidney Injury Drugs Sales Market Share by Region (2027-2032) Table 23. Global Acute Kidney Injury Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Acute Kidney Injury Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Acute Kidney Injury Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Acute Kidney Injury Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Acute Kidney Injury Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Acute Kidney Injury Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Acute Kidney Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Acute Kidney Injury Drugs Manufacturers, Product Type & Application Table 31. Global Acute Kidney Injury Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Acute Kidney Injury Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Acute Kidney Injury Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Acute Kidney Injury Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 41. Global Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 42. Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2026) Table 43. Global Acute Kidney Injury Drugs Sales Market Share by Type (2027-2032) Table 44. Global Acute Kidney Injury Drugs Price by Type (2021-2026) & (US$/unit) Table 45. Global Acute Kidney Injury Drugs Price by Type (2027-2032) & (US$/unit) Table 46. Global Acute Kidney Injury Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Acute Kidney Injury Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 54. Global Acute Kidney Injury Drugs Sales Market Share by Application (2021-2026) Table 55. Global Acute Kidney Injury Drugs Sales Market Share by Application (2027-2032) Table 56. Global Acute Kidney Injury Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Acute Kidney Injury Drugs Price by Application (2027-2032) & (US$/unit) Table 58. Fresenius Medical Care AG & Co. KGaA Company Information Table 59. Fresenius Medical Care AG & Co. KGaA Business Overview Table 60. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio Table 62. Fresenius Medical Care AG & Co. KGaA Recent Development Table 63. B. Braun Melsungen AG Company Information Table 64. B. Braun Melsungen AG Business Overview Table 65. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio Table 67. B. Braun Melsungen AG Recent Development Table 68. Quark Pharmaceuticals Company Information Table 69. Quark Pharmaceuticals Business Overview Table 70. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio Table 72. Quark Pharmaceuticals Recent Development Table 73. Baxter International Company Information Table 74. Baxter International Business Overview Table 75. Baxter International Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Baxter International Acute Kidney Injury Drugs Product Portfolio Table 77. Baxter International Recent Development Table 78. LG Chem Company Information Table 79. LG Chem Business Overview Table 80. LG Chem Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. LG Chem Acute Kidney Injury Drugs Product Portfolio Table 82. LG Chem Recent Development Table 83. Asahi Kasei Medical Company Information Table 84. Asahi Kasei Medical Business Overview Table 85. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio Table 87. Asahi Kasei Medical Recent Development Table 88. Angion Biomedica Corp Company Information Table 89. Angion Biomedica Corp Business Overview Table 90. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio Table 92. Angion Biomedica Corp Recent Development Table 93. North America Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 96. North America Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 97. North America Acute Kidney Injury Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 98. North America Acute Kidney Injury Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 99. North America Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 102. North America Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 103. North America Acute Kidney Injury Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 104. North America Acute Kidney Injury Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 105. North America Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Acute Kidney Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 109. North America Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 110. North America Acute Kidney Injury Drugs Sales by Country (2027-2032) & (k units) Table 111. North America Acute Kidney Injury Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 112. North America Acute Kidney Injury Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 113. United States Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 114. Canada Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 115. Mexico Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 116. Europe Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 119. Europe Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 120. Europe Acute Kidney Injury Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 121. Europe Acute Kidney Injury Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 122. Europe Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 125. Europe Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 126. Europe Acute Kidney Injury Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 127. Europe Acute Kidney Injury Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 128. Europe Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Acute Kidney Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. Europe Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 133. Europe Acute Kidney Injury Drugs Sales by Country (2027-2032) & (k units) Table 134. Europe Acute Kidney Injury Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 135. Europe Acute Kidney Injury Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 136. Germany Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 137. France Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 138. U.K. Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 139. Italy Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 140. Russia Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 141. Spain Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 144. Sweden Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 145. Poland Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 146. China Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. China Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. China Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 149. China Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 150. China Acute Kidney Injury Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 151. China Acute Kidney Injury Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 152. China Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. China Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. China Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 155. China Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 156. China Acute Kidney Injury Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 157. China Acute Kidney Injury Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 161. Asia Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 162. Asia Acute Kidney Injury Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 163. Asia Acute Kidney Injury Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 164. Asia Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 167. Asia Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 168. Asia Acute Kidney Injury Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 169. Asia Acute Kidney Injury Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Acute Kidney Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. Asia Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 175. Asia Acute Kidney Injury Drugs Sales by Country (2027-2032) & (k units) Table 176. Asia Acute Kidney Injury Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 177. Asia Acute Kidney Injury Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 178. Japan Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 179. South Korea Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 180. India Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 181. Australia Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Acute Kidney Injury Drugs Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Acute Kidney Injury Drugs Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 187. SAMEA Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 188. SAMEA Acute Kidney Injury Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 189. SAMEA Acute Kidney Injury Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 190. SAMEA Acute Kidney Injury Drugs Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Acute Kidney Injury Drugs Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 193. SAMEA Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 194. SAMEA Acute Kidney Injury Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 195. SAMEA Acute Kidney Injury Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 196. SAMEA Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Acute Kidney Injury Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. SAMEA Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 201. SAMEA Acute Kidney Injury Drugs Sales by Country (2027-2032) & (k units) Table 202. SAMEA Acute Kidney Injury Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 203. SAMEA Acute Kidney Injury Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 204. Brazil Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 205. Argentina Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 206. Chile Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 207. Colombia Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 208. Peru Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 210. Israel Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 211. UAE Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 212. Turkey Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 213. Iran Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 214. Egypt Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Acute Kidney Injury Drugs Distributors List Table 218. Acute Kidney Injury Drugs Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Acute Kidney Injury Drugs Image Figure 2. Global Acute Kidney Injury Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acute Kidney Injury Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intrinsic Acute Kidney Injury Image Figure 5. Postrenal Acute Kidney Injury Image Figure 6. Prerenal Acute Kidney Injury Image Figure 7. Others Image Figure 8. Global Acute Kidney Injury Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Acute Kidney Injury Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Acute Kidney Injury Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Acute Kidney Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Acute Kidney Injury Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Acute Kidney Injury Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Acute Kidney Injury Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Acute Kidney Injury Drugs Sales (2021-2032) & (k units) Figure 18. Global Acute Kidney Injury Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Acute Kidney Injury Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Acute Kidney Injury Drugs Sales YoY (2021-2032) & (k units) Figure 21. Europe Acute Kidney Injury Drugs Sales YoY (2021-2032) & (k units) Figure 22. China Acute Kidney Injury Drugs Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Acute Kidney Injury Drugs Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Acute Kidney Injury Drugs Sales YoY (2021-2032) & (k units) Figure 25. Global Acute Kidney Injury Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Acute Kidney Injury Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Acute Kidney Injury Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Acute Kidney Injury Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Acute Kidney Injury Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Acute Kidney Injury Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Acute Kidney Injury Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Acute Kidney Injury Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Acute Kidney Injury Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Acute Kidney Injury Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Acute Kidney Injury Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Acute Kidney Injury Drugs Revenue Share by Type (2021-2032) Figure 41. North America Acute Kidney Injury Drugs Sales Share by Type (2021-2032) Figure 42. North America Acute Kidney Injury Drugs Revenue Share by Application (2021-2032) Figure 43. North America Acute Kidney Injury Drugs Sales Share by Application (2021-2032) Figure 44. North America Acute Kidney Injury Drugs Revenue Share by Country (2021-2032) Figure 45. North America Acute Kidney Injury Drugs Sales Share by Country (2021-2032) Figure 46. Europe Acute Kidney Injury Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Acute Kidney Injury Drugs Sales Share by Type (2021-2032) Figure 48. Europe Acute Kidney Injury Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Acute Kidney Injury Drugs Sales Share by Application (2021-2032) Figure 50. Europe Acute Kidney Injury Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Acute Kidney Injury Drugs Sales Share by Country (2021-2032) Figure 52. China Acute Kidney Injury Drugs Revenue Share by Type (2021-2032) Figure 53. China Acute Kidney Injury Drugs Sales Share by Type (2021-2032) Figure 54. China Acute Kidney Injury Drugs Revenue Share by Application (2021-2032) Figure 55. China Acute Kidney Injury Drugs Sales Share by Application (2021-2032) Figure 56. Asia Acute Kidney Injury Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Acute Kidney Injury Drugs Sales Share by Type (2021-2032) Figure 58. Asia Acute Kidney Injury Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Acute Kidney Injury Drugs Sales Share by Application (2021-2032) Figure 60. Asia Acute Kidney Injury Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Acute Kidney Injury Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Acute Kidney Injury Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Acute Kidney Injury Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Acute Kidney Injury Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Acute Kidney Injury Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Acute Kidney Injury Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Acute Kidney Injury Drugs Sales Share by Country (2021-2032) Figure 68. Acute Kidney Injury Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Acute Kidney Injury Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Intrinsic Acute Kidney Injury
  • Postrenal Acute Kidney Injury
  • Prerenal Acute Kidney Injury
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Quark Pharmaceuticals
  • Baxter International
  • LG Chem
  • Asahi Kasei Medical
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acute Kidney Injury Drugs Market by Type
  3. 1.2.1 Global Acute Kidney Injury Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intrinsic Acute Kidney Injury
  5. 1.2.3 Postrenal Acute Kidney Injury
  6. 1.2.4 Prerenal Acute Kidney Injury
  7. 1.2.5 Others
  8. 1.3 Acute Kidney Injury Drugs Market by Application
  9. 1.3.1 Global Acute Kidney Injury Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Acute Kidney Injury Drugs Market Dynamics
  1. 2.1 Acute Kidney Injury Drugs Industry Trends
  2. 2.2 Acute Kidney Injury Drugs Industry Drivers
  3. 2.3 Acute Kidney Injury Drugs Industry Opportunities and Challenges
  4. 2.4 Acute Kidney Injury Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Acute Kidney Injury Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Acute Kidney Injury Drugs Revenue by Region
  3. 3.2.1 Global Acute Kidney Injury Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acute Kidney Injury Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Acute Kidney Injury Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Acute Kidney Injury Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Acute Kidney Injury Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Acute Kidney Injury Drugs Sales by Region
  9. 3.4.1 Global Acute Kidney Injury Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Acute Kidney Injury Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Acute Kidney Injury Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Acute Kidney Injury Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Acute Kidney Injury Drugs Revenue by Manufacturers
  2. 4.1.1 Global Acute Kidney Injury Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Acute Kidney Injury Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Acute Kidney Injury Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acute Kidney Injury Drugs Sales by Manufacturers
  6. 4.2.1 Global Acute Kidney Injury Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Acute Kidney Injury Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Acute Kidney Injury Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Acute Kidney Injury Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Acute Kidney Injury Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Acute Kidney Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Acute Kidney Injury Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Acute Kidney Injury Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Acute Kidney Injury Drugs Market CR5 and HHI
  16. 4.8.2 2025 Acute Kidney Injury Drugs Tier 1, Tier 2, and Tier 3
5 Acute Kidney Injury Drugs Market by Type
  1. 5.1 Global Acute Kidney Injury Drugs Revenue by Type
  2. 5.1.1 Global Acute Kidney Injury Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Acute Kidney Injury Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Acute Kidney Injury Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Acute Kidney Injury Drugs Sales by Type
  6. 5.2.1 Global Acute Kidney Injury Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acute Kidney Injury Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Acute Kidney Injury Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Acute Kidney Injury Drugs Price by Type
6 Acute Kidney Injury Drugs Market by Application
  1. 6.1 Global Acute Kidney Injury Drugs Revenue by Application
  2. 6.1.1 Global Acute Kidney Injury Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Acute Kidney Injury Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Acute Kidney Injury Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Acute Kidney Injury Drugs Sales by Application
  6. 6.2.1 Global Acute Kidney Injury Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Acute Kidney Injury Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Acute Kidney Injury Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Acute Kidney Injury Drugs Price by Application
7 Company Profiles
  1. 7.1 Fresenius Medical Care AG & Co. KGaA
  2. 7.1.1 Fresenius Medical Care AG & Co. KGaA Company Information
  3. 7.1.2 Fresenius Medical Care AG & Co. KGaA Business Overview
  4. 7.1.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio
  6. 7.1.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
  7. 7.2 B. Braun Melsungen AG
  8. 7.2.1 B. Braun Melsungen AG Company Information
  9. 7.2.2 B. Braun Melsungen AG Business Overview
  10. 7.2.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio
  12. 7.2.5 B. Braun Melsungen AG Recent Developments
  13. 7.3 Quark Pharmaceuticals
  14. 7.3.1 Quark Pharmaceuticals Company Information
  15. 7.3.2 Quark Pharmaceuticals Business Overview
  16. 7.3.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio
  18. 7.3.5 Quark Pharmaceuticals Recent Developments
  19. 7.4 Baxter International
  20. 7.4.1 Baxter International Company Information
  21. 7.4.2 Baxter International Business Overview
  22. 7.4.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Baxter International Acute Kidney Injury Drugs Product Portfolio
  24. 7.4.5 Baxter International Recent Developments
  25. 7.5 LG Chem
  26. 7.5.1 LG Chem Company Information
  27. 7.5.2 LG Chem Business Overview
  28. 7.5.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 LG Chem Acute Kidney Injury Drugs Product Portfolio
  30. 7.5.5 LG Chem Recent Developments
  31. 7.6 Asahi Kasei Medical
  32. 7.6.1 Asahi Kasei Medical Company Information
  33. 7.6.2 Asahi Kasei Medical Business Overview
  34. 7.6.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio
  36. 7.6.5 Asahi Kasei Medical Recent Developments
  37. 7.7 Angion Biomedica Corp
  38. 7.7.1 Angion Biomedica Corp Company Information
  39. 7.7.2 Angion Biomedica Corp Business Overview
  40. 7.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio
  42. 7.7.5 Angion Biomedica Corp Recent Developments
8 North America
  1. 8.1 North America Acute Kidney Injury Drugs Market Size by Type
  2. 8.1.1 North America Acute Kidney Injury Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Acute Kidney Injury Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Acute Kidney Injury Drugs Price by Type (2021-2032)
  5. 8.2 North America Acute Kidney Injury Drugs Market Size by Application
  6. 8.2.1 North America Acute Kidney Injury Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Acute Kidney Injury Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Acute Kidney Injury Drugs Price by Application (2021-2032)
  9. 8.3 North America Acute Kidney Injury Drugs Market Size by Country
  10. 8.3.1 North America Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Acute Kidney Injury Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Acute Kidney Injury Drugs Market Size by Type
  2. 9.1.1 Europe Acute Kidney Injury Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Acute Kidney Injury Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Acute Kidney Injury Drugs Price by Type (2021-2032)
  5. 9.2 Europe Acute Kidney Injury Drugs Market Size by Application
  6. 9.2.1 Europe Acute Kidney Injury Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Acute Kidney Injury Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Acute Kidney Injury Drugs Price by Application (2021-2032)
  9. 9.3 Europe Acute Kidney Injury Drugs Market Size by Country
  10. 9.3.1 Europe Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Acute Kidney Injury Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Acute Kidney Injury Drugs Market Size by Type
  2. 10.1.1 China Acute Kidney Injury Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Acute Kidney Injury Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Acute Kidney Injury Drugs Price by Type (2021-2032)
  5. 10.2 China Acute Kidney Injury Drugs Market Size by Application
  6. 10.2.1 China Acute Kidney Injury Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Acute Kidney Injury Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Acute Kidney Injury Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acute Kidney Injury Drugs Market Size by Type
  2. 11.1.1 Asia Acute Kidney Injury Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Acute Kidney Injury Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Acute Kidney Injury Drugs Price by Type (2021-2032)
  5. 11.2 Asia Acute Kidney Injury Drugs Market Size by Application
  6. 11.2.1 Asia Acute Kidney Injury Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Acute Kidney Injury Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Acute Kidney Injury Drugs Price by Application (2021-2032)
  9. 11.3 Asia Acute Kidney Injury Drugs Market Size by Country
  10. 11.3.1 Asia Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Acute Kidney Injury Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acute Kidney Injury Drugs Market Size by Type
  2. 12.1.1 SAMEA Acute Kidney Injury Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Acute Kidney Injury Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Acute Kidney Injury Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Acute Kidney Injury Drugs Market Size by Application
  6. 12.2.1 SAMEA Acute Kidney Injury Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Acute Kidney Injury Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Acute Kidney Injury Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Acute Kidney Injury Drugs Market Size by Country
  10. 12.3.1 SAMEA Acute Kidney Injury Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Acute Kidney Injury Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Acute Kidney Injury Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Acute Kidney Injury Drugs Value Chain Analysis
  2. 13.1.1 Acute Kidney Injury Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Acute Kidney Injury Drugs Production Mode & Process
  6. 13.2 Acute Kidney Injury Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Acute Kidney Injury Drugs Distributors
  9. 13.2.3 Acute Kidney Injury Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst